Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Liebchen

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Intensive Care Medicine|January 31, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matterUwe Liebchen, Josef Briegel, Alexander Brinkmann, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 1, 2014
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditionsAlexander Kratzer, Uwe Liebchen, Michael Schleibinger, et al.
Die Anaesthesiologie|September 14, 2023
[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems]Caroline Gräfe, Lorenz Weidhase, Uwe Liebchen, et al.
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Journal of Medical Case Reports|September 9, 2025
Challenges in the use of the CytoSorb<sup>®</sup> adsorber in an intensive care patient with liver dysfunction of unknown origin: a case reportCaroline Gräfe, Michael Paal, Michael Irlbeck, et al.
Case Reports in Critical Care|October 15, 2021
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine StormAlice-Christin Acevedo, Michael Zoller, Christina Scharf, et al.
Annals of Intensive Care|July 22, 2021
Can the cytokine adsorber CytoSorb<sup>®</sup> help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysisChristina Scharf, Ines Schroeder, Michael Paal, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2019
Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serumCarina Schuster, Michael Paal, Johanna Lindner, et al.
Infection|September 4, 2020
Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patientsInes Schroeder, Karl Dichtl, Uwe Liebchen, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine|January 31, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matterUwe Liebchen, Josef Briegel, Alexander Brinkmann, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 1, 2014
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditionsAlexander Kratzer, Uwe Liebchen, Michael Schleibinger, et al.
Die Anaesthesiologie|September 14, 2023
[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems]Caroline Gräfe, Lorenz Weidhase, Uwe Liebchen, et al.
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Journal of Medical Case Reports|September 9, 2025
Challenges in the use of the CytoSorb<sup>®</sup> adsorber in an intensive care patient with liver dysfunction of unknown origin: a case reportCaroline Gräfe, Michael Paal, Michael Irlbeck, et al.
Case Reports in Critical Care|October 15, 2021
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine StormAlice-Christin Acevedo, Michael Zoller, Christina Scharf, et al.
Annals of Intensive Care|July 22, 2021
Can the cytokine adsorber CytoSorb<sup>®</sup> help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysisChristina Scharf, Ines Schroeder, Michael Paal, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2019
Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serumCarina Schuster, Michael Paal, Johanna Lindner, et al.
Infection|September 4, 2020
Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patientsInes Schroeder, Karl Dichtl, Uwe Liebchen, et al.
Pageof 7